Literature DB >> 3897077

Clinical evaluation of ceftazidime in high risk patients.

M Montagnani, C Bianchini, R Nami, G Pavese, L Papini, C Gennari.   

Abstract

Ceftazidime was used in 19 patients at high risk owing to severe impairment of natural defense systems. The therapeutic efficacy and adverse reactions produced by cephalosporin, as evaluated on the basis of the results of clinical investigations and laboratory tests, were regarded as positive.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897077

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  1 in total

1.  [Treatment of infections of the lower urinary tract caused by multiresistant gram-negative pathogens, with ceftazidime in monotherapy of patients with spinal cord injuries].

Authors:  H J Hachen
Journal:  Infection       Date:  1987       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.